Abstract
Interferons are important in regulating cell growth and differentiation, immune function and initiating anti-viral responses. While the pleotrophic actions of interferons have been well documented, the molecular mechanisms underpinning their biological effects have not been fully characterized. IFI 16 is a member of the interferon-inducible HIN-200 family of nuclear proteins, which we have recently shown can function as a potent transcriptional repressor. A murine member of the HIN-200 family, p202, can indirectly interact with p53 via the p53 binding protein (p53bp) and inhibit p53-mediated transcriptional activation. The binding activity of p202 to p53bp was shown to require the conserved MFHATVAT motif present in all 200 amino acid repeat regions of HIN-200 proteins. Given that IFI 16 contains two MFHATVAT motifs, we sought to determine whether IFI 16 may form a complex with p53 and if so to ascertain the functional significance of this interaction. We demonstrate that IFI 16 can directly bind to the C-terminal region of p53 and augment p53-mediated transcriptional activation without altering the steady state levels of p53. Thus, in addition to its ability to directly regulate gene expression, IFI 16 can also modulate the transcription function of other cellular transcription factors. These findings demonstrate a possible link between gene induction following interferon stimulation and p53-mediated cellular events.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Arany I, Brysk MM, Calhoun KH and Tyring SK. . 1996 In Vivo 10: 119–123.
Burrus GR, Briggs JA and Briggs RC. . 1992 J. Cell. Biochem. 48: 190–202.
Chen J, Marechal V and Levine AJ. . 1993 Mol. Cell. Biol. 13: 4107–4114.
Choubey D and Gutterman JU. . 1997 Oncogene 15: 291–301.
Choubey D and Lengyel P. . 1995 J. Biol. Chem. 270: 6134–6140.
Choubey D, Li S-J, Datta B, Gutterman JU and Lengyel P. . 1996 EMBO J. 15: 5668–5678.
Choubey D, Snoddy J, Chaturvedi V, Toniato E, Opdenakker G, Thakur A, Samanta H, Engel DA and Lengyel P. . 1989 J. Biol. Chem. 264: 17182–17189.
Cuddihy AR, Li S, Tam NWM, Wong AH-T, Taya Y, Abraham N, Bell JC and Koromilas AE. . 1999 Mol. Cell. Biol. 19: 2475–2484.
Darnell JE, Kerr IM and Stark GR. . 1994 Science 264: 1415–1421.
Datta B, Li B, Choubey D, Nallur G and Lengyel P. . 1996 J. Biol. Chem. 271: 27544–27555.
Datta B, Min W, Burma S and Lengyel P. . 1998 Mol. Cell. Biol. 18: 1074–1083.
Dawson MJ and Trapani JA. . 1995 Bioch. Biophys. Res. Commun. 214: 152–162.
Dawson MJ and Trapani JA. . 1996 J. Leuk. Biol. 60: 1–7.
DeYoung KL, Ray ME, Jonstone RW, Su YA, Anzick SL, Meltzer PS, Trapani JA and Trent JM. . 1997 Oncogene 15: 453–457.
Duhl DM, Gaczynski M, Olinski R and Briggs RC. . 1989 J. Cell. Physiol. 141: 148–153.
El-Deiry WS, Toniko T, Velculescu VE, Levy DB, Parson R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.
Fuchs SY, Adler V, Buschmann T, Wu X and Ronai Z. . 1998 Oncogene 17: 2543–2547.
Graham FL, Smiley J, Russell WC and Nairn R. . 1977 J. Gen. Virol. 36: 59–74.
Gribaudo G, Ravaglia S, Guandalini L, Riera L, Gariglio M and Landolfo S. . 1997 Eur. J. Biochem. 249: 258–264.
Gu W and Roeder RG. . 1997 Cell 90: 595–606.
Gutterman JU and Choubey D. . 1999 Cell Growth Diff. 10: 93–100.
Hobeika AC, Etienne W, Torres BA, Johnson HM and Subramaniam PS. . 1999 J. Interferon Cytokine Res. 19: 1351–1361.
Hupp TR, Meek DW, Midgley CA and Lane DP. . 1992 Cell 71: 875–886.
Hupp TR, Meek DW, Midgley CA and Lane DP. . 1993 Nucleic Acids Res. 21: 3167–3174.
Johnstone RW, Kerry JA and Trapani JA. . 1998a J. Biol. Chem. 273: 17172–17177.
Johnstone RW, Kershaw MH and Trapani JA. . 1998b Biochemistry 37: 11924–11931.
Johnstone RW and Trapani JA. . 1999 Mol. Cell. Biol. 19: 5833–5838.
Kaelin Jr, WG, Pallas DC, DeCaprio JA, Faye FJ and Livingston DM. . 1991 Cell 64: 521–531.
Koul D, Lapushin R, Xu H-J, Mills GB, Gutterman JU and Choubey D. . 1998 Bioch. Biophys. Res. Commun. 247: 379–382.
Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R and Brady JN. . 1998 J. Biol. Chem. 273: 33048–33053.
Landolfo S, Gariglio M, Gribaudo G and Lembo D. . 1998 Biochimie. 80: 721–728.
Lembo D, Angeretti A, Benefazio S, Hertel L, Gariglio M, Novelli F and Landolfo S. . 1995 J. Biol. Reg. Homeo. Agents 9: 42–46.
Lembo M, Sacchi C, Zappador C, Bellomo G, Gaboli M, Pandolfi PP, Gariglio M and Landolfo S. . 1998 Oncogene 16: 1543–1551.
Lengyel P, Choubey D, Li S-J and Datta B. . 1995 Sem. Virol. 6: 203–213.
Liu C-J, Wang H and Lengyel P. . 1999 EMBO J. 18: 2845–2854.
Marston NJ, Ludwig RL and Vousden KH. . 1998 Oncogene 16: 3123–3131.
Matsuzawa S-I, Takayama S, Froesch BA, Zapata JM and Reed JC. . 1998 EMBO J. 17: 2736–2747.
McLean IW and Nakane PK. . 1974 J. Histochem. Cytochem. 22: 1077–1083.
Min W, Ghosh S and Lengyel P. . 1996 Mol. Cell. Biol. 16: 359–368.
Miyashita T and Reed JC. . 1995 Cell 80: 293–299.
Rodriguez MS, Desterro JP, Lain S, Midgly CA, Lane DP and Hay RT. . 1999 EMBO J. 18: 6455–6461.
Scheffner M, Huibregtse JM, Vierstra RD and Howley PM. . 1993 Cell 75: 495–505.
Shaw P, Freeman J, Bovey R and Iggo R. . 1996 Oncogene 12: 921–930.
Shi Y, Lee J-S and Galvin KM. . 1997 Biochim. Biophys. Acta 1332: 49–66.
Shi Y, Seto E, Chang LS and Shenk T. . 1991 Cell 67: 377–388.
Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD. . 1998 Annu. Rev. Biochem. 67: 227–264.
Stenger JE, Tegtmeyer P, Mayr GA, Reed M, Wang Y, Wang P, Hough PVC and Mastrangelo IA. . 1994 EMBO J. 13: 6011–6020.
Subramanium PS and Johnson HM. . 1997 J. Interferon Cytokine Res. 17: 11–15.
Tanaka N, Ishihara M, Lamphier MS, Nozawa H, Matsuyama T, Mak TW, Aizawa S, Tokino T, Oren M and Tanhiguchi T. . 1996 Nature 382: 816–818.
Tannenbaum CS, Major J, Ohmori Y and Hamilton TA. . 1993 J. Leuk. Biol. 53: 563–568.
Trapani JA, Browne KA, Dawson MJ, Ramsay RG, Eddy RL, Shows TB, White PC and Dupont B. . 1992 Immunogenetics 36: 369–376.
Trapani JA, Browne KA, Dawson MJ and Smyth MJ. . 1993 Biochem. Biophys. Res. Commun. 195: 910–920.
Wang Z-Y, Qiu QQ and Deuel TE. . 1993 J. Biol. Chem. 268: 9972–9975.
Xie J, Briggs JA and Briggs RC. . 1998 J. Cell. Biochem. 70: 489–506.
Yan DH, Wen Y, Spohn B, Choubey D, Gutterman JU and Hung MC. . 1999 Oncogene 18: 807–811.
Yew PR and Berk AJ. . 1992 Nature 357: 82–85.
Acknowledgements
We thank Drs CJP Clarke and SM Russell for helpful discussions and Drs A Cuddihy, P Lambert and P Hinds for reagents. RW Johnstone is a Wellcome Trust Senior Research Fellow and JA Trapani is a Principal Research Fellow of the National Health and Medical Research Council of Australia. This work is supported by a project grant from the NH&MRC and by the Wellcome Trust.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Johnstone, R., Wei, W., Greenway, A. et al. Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16. Oncogene 19, 6033–6042 (2000). https://doi.org/10.1038/sj.onc.1204005
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204005
Keywords
This article is cited by
-
Type I IFN stimulates IFI16-mediated aromatase expression in adipocytes that promotes E2-dependent growth of ER-positive breast cancer
Cellular and Molecular Life Sciences (2022)
-
Comprehensive analysis identifies IFI16 as a novel signature associated with overall survival and immune infiltration of skin cutaneous melanoma
Cancer Cell International (2021)
-
Molecular characterization of woodchuck IFI16 and AIM2 and their expression in woodchucks infected with woodchuck hepatitis virus (WHV)
Scientific Reports (2016)
-
Nutlin-3-induced redistribution of chromatin-bound IFI16 in human hepatocellular carcinoma cells in vitro is associated with p53 activation
Acta Pharmacologica Sinica (2015)
-
The Multidrug Transporter P-Glycoprotein: A Mediator of Melanoma Invasion?
Journal of Investigative Dermatology (2008)